Europe Brain Cancer Diagnostic Market to 2032
Overview
The Europe Brain Cancer Diagnostic Market is expected to reach a 2,669.97 USD Billion by 2032 and is projected to grow at a CAGR of 26.93% from 2025 to 2032.
Europe Brain Cancer Diagnostic Market 2018-2032 USD Billion
Europe Brain Cancer Diagnostic Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 698.94 USD Billion
- Projected Market Size (2032): 2,669.97 USD Billion
- CAGR (2025-2032): 26.93%
Key Findings of Europe Brain Cancer Diagnostic Market
- The Europe Brain Cancer Diagnostic Market was valued at 698.94 USD Billion in 2024.
- The Europe Brain Cancer Diagnostic Market is likely to grow at a CAGR of 26.93% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Imaging Test in Test Segment accounted for the largest share of the market with a revenue of 244.04 USD Billion
- The fastest growing segment 35-65 in Age Group Segment grew Fastest with a CAGR of 29.08% during the forecast period from 2024 to 2032.
Europe Brain Cancer Diagnostic Market Scope
- Others
- Ambulatory Surgical Centers
- Diagnostic Centers & Research Institutes
- Specialty Clinics
- Hospitals
- 21-34
- Below 21
- 65 and above
- 35-65
- Others
- Oligodendroglioma
- Acoustic Neuroma
- Astrocytomas
- Meningiomas
- Glioblastoma Multiforme
- Others
- Biopsy
- Lumbar Puncture
- Electroencephalography (EEG)
- Molecular Testing
- Imaging Test
Europe Brain Cancer Diagnostic Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 698.94 USD Billion |
| Market Value in 2032 | 2,669.97 USD Billion |
| CAGR (2025-2032) | 26.93% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Age Group,Cancer,Test |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 698.94 USD Billion in 2024
- Key Country: Germany, leading in terms of revenue with value of 104.28 USD Billion in 2024.
Segments and Scope
-
Europe Brain Cancer Diagnostic Market to 2032, By End User
- Hospitals is the largest segment in Europe Brain Cancer Diagnostic Market to 2032 with a revenue of 238.88 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Europe Brain Cancer Diagnostic Market to 2032 with a Growth rate of 28.83 % in forecast period 2025-2032.
-
Europe Brain Cancer Diagnostic Market to 2032, By Age Group
- 35-65 is the largest segment in Europe Brain Cancer Diagnostic Market to 2032 with a revenue of 226.64 USD Billion in the year 2024.
- 35-65 is the Fastest growing segment in Europe Brain Cancer Diagnostic Market to 2032 with a Growth rate of 29.08 % in forecast period 2025-2032.
-
Europe Brain Cancer Diagnostic Market to 2032, By Cancer
- Glioblastoma Multiforme is the largest segment in Europe Brain Cancer Diagnostic Market to 2032 with a revenue of 216.53 USD Billion in the year 2024.
- Glioblastoma Multiforme is the Fastest growing segment in Europe Brain Cancer Diagnostic Market to 2032 with a Growth rate of 28.83 % in forecast period 2025-2032.
-
Europe Brain Cancer Diagnostic Market to 2032, By Test
- Imaging Test is the largest segment in Europe Brain Cancer Diagnostic Market to 2032 with a revenue of 244.04 USD Billion in the year 2024.
- Imaging Test is the Fastest growing segment in Europe Brain Cancer Diagnostic Market to 2032 with a Growth rate of 28.79 % in forecast period 2025-2032.
Europe Brain Cancer Diagnostic Market Company Share Analysis
| Company Name |
|
||
| NIHON KOHDEN CORPORATION | |||
| Neusoft Corporation | |||
| Koninklijke Philips N.V. | |||
| CANON MEDICAL SYSTEMS CORPORATION | |||
| Siemens Healthcare GmbH | |||
Europe Brain Cancer Diagnostic Market Geographical Sales Distribution, 2018-2032 USD Billion
Europe Brain Cancer Diagnostic Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Europe Brain Cancer Diagnostic Market Scope
- Others
- Ambulatory Surgical Centers
- Diagnostic Centers & Research Institutes
- Specialty Clinics
- Hospitals
- 21-34
- Below 21
- 65 and above
- 35-65
- Others
- Oligodendroglioma
- Acoustic Neuroma
- Astrocytomas
- Meningiomas
- Glioblastoma Multiforme
- Others
- Biopsy
- Lumbar Puncture
- Electroencephalography (EEG)
- Molecular Testing
- Imaging Test
Frequently Asked Questions
Europe Brain Cancer Diagnostic Market Company Profiling
Frequently Asked Questions
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.